However, recent molecular classifications have identified subsets of breast tumors withhigh androgen receptor expression, including "luminal androgen receptor (LAR) tumors" and "molecular apocrine tumors" (MATs), which mayhave implications for targeted therapies [63]. Here, AR is linked to apocrine sweat gland neoplasm.